Journal of Big Data Research

JBR Waiver Program 2025

New Year, New Horizons – Harnessing Big Data for Global Impact
 

The Journal of Big Data Research (JBR) is proud to unveil its Waiver Program 2025, designed to celebrate research that harnesses the power of data to address challenges and create opportunities across diverse fields. From September 01 to September 30, 2025, submit your manuscript and enjoy up to 20% on processing charges.

Your expertise can drive breakthroughs in healthcare, artificial intelligence, finance, education, urban planning, sustainability, energy, transportation, retail analytics, cybersecurity, and beyond. Let’s make this year a turning point in data-driven innovation!

Big Data Across Every Sector

Your research could transform industries, empower decision-making, and address global challenges. Share your work with the world through JBR’s Waiver Program 2025. Let’s shape the future—one dataset at a time.

Submit Now

Why Publish with JBR?

• Accelerated Review and Publication: Waiver submissions are prioritized for faster decision timelines.
• Global Visibility Across Sectors: Exceptional research will be featured in our Big Data Trailblazers Spotlight, amplifying its reach across industries.
• Reduced Costs, Bigger Impact: Waivers ensure your groundbreaking work is accessible globally, free from financial constraints.

How to Submit

Submitting your manuscript to JBR is simple and flexible. Choose from one of the following methods:

• Online Submission Form: Submit directly through our online portal quickly and easily.
• Email Submission: Prefer submitting by email? Send your manuscript to [email protected].
• Author Registration Link: Register as an author and manage your submissions through our secure portal.

Submit to Our Sister Journals

Explore more options by submitting your research to our sister journals:

• Journal of Cancer Genetics and Biomarkers (JCGB) – Ideal for research integrating data science, algorithms, or computational methods into cancer research and genetic biomarker studies.

• Journal of Current Viruses and Treatment Methodologies (JVAT) – For research that applies data science or algorithms to viral treatments or epidemiological studies.
• Journal of Family Medicine (JFM) – For data-driven research intersecting with family medicine or public health, especially if focused on viruses.
• International Journal of Coronaviruses (IJCV) – Suitable for research utilizing algorithms and data science techniques in COVID-19 or coronavirus studies.
• Journal of Biotechnology and Biomedical Science (JBBS) – For research leveraging data science and algorithms in biotechnology and biomedical innovations.

FAQS

1. Can I apply for multiple waivers?
   Yes, but only the highest waiver percentage will be applied.
2. When will I know if my waiver is approved?
   You’ll hear back within 7 business days of submission.
3. Do I need to pay upfront?
   No, APCs are adjusted after waiver approval.

Contact Us

For editorial inquiries or submission assistance, feel free to reach out to our team at:
[email protected]

Last Updated on September 01, 2025